title: Effects of rifampicin (rifampin) on the pharmacokinetics and safety of ambrisentan in healthy subjects: a single-sequence, open-label study.
authors.affiliation: Gilead Sciences Inc., Boulder, Colorado, 80301, USA. Brooke.Harrison@Colorado.edu.
authors.forename: Brooke
authors.initials: B
authors.lastname: Harrison
authors.affiliation: GlaxoSmithKline, King of Prussia, Pennsylvania, USA.
authors.forename: Mindy H
authors.initials: MH
authors.lastname: Magee
authors.affiliation: Gilead Sciences Inc., Boulder, Colorado, 80301, USA.
authors.forename: Arun
authors.initials: A
authors.lastname: Mandagere
authors.affiliation: Gilead Sciences Inc., Boulder, Colorado, 80301, USA.
authors.forename: Gennyne
authors.initials: G
authors.lastname: Walker
authors.affiliation: Gilead Sciences Inc., Boulder, Colorado, 80301, USA.
authors.forename: Christopher
authors.initials: C
authors.lastname: Dufton
authors.affiliation: GlaxoSmithKline, King of Prussia, Pennsylvania, USA.
authors.forename: Linda S
authors.initials: LS
authors.lastname: Henderson
authors.affiliation: Gilead Sciences Inc., Boulder, Colorado, 80301, USA.
authors.forename: Ramesh
authors.initials: R
authors.lastname: Boinpally